Opposing regulation of PROX1 by interleukin-3 receptor and NOTCH directs differential host cell fate reprogramming by Kaposi sarcoma herpes virus

PLoS Pathogens

Volumn 8, Issue 6, 2012, Pages

  Yoo, Jaehyuk ^a   Lee, Ha Neul ^a   Choi, Inho ^a   Choi, Dongwon ^a   Chung, Hee Kyoung ^a   Kim, Kyu Eui ^a   Lee, Sunju ^a   Aguilar, Berenice ^a   Kang, Jinjoo ^a   Park, Eunkyung ^a   Lee, Yong Suk ^a   Maeng, Yong Sun ^a   Kim, Nam Yoon ^a   Koh, Chester J ^b   Hong, Young Kwon ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD123 ANTIGEN; CELL PROTEIN; NOTCH RECEPTOR; PROTEIN HEY1; PROTEIN PROX1; REGULATOR PROTEIN; STAT5 PROTEIN; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; INTERLEUKIN 3 RECEPTOR; PROSPERO RELATED HOMEOBOX 1 PROTEIN; PROSPERO-RELATED HOMEOBOX 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL FATE; DOWN REGULATION; ENDOTHELIUM CELL; GENE REPRESSION; HOST CELL; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; NUCLEAR REPROGRAMMING; PROMOTER REGION; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR ENDOTHELIUM; VIRUS PATHOGENESIS; CELL CULTURE; CELL LINEAGE; DNA MICROARRAY; GEL MOBILITY SHIFT ASSAY; HERPES VIRUS INFECTION; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIAL CELLS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HOMEODOMAIN PROTEINS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, INTERLEUKIN-3; RECEPTORS, NOTCH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84864051822     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002770     Document Type: Article

References (57)

1. Pantanowitz L, Stebbing J, Dezube BJ, editors (2010) Kaposi Sarcoma. A Model of Oncogenesis. Kerala, Indai: Research Signpost.
2. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
3. Kedes DH, Lagunoff M, Renne R, Ganem D, (1997) Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J Clin Invest 100: 2606-2610.
4. Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, et al. (1997) The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 71: 5915-5921.
5. Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A, et al. (1998) A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 72: 8309-8315.
6. Muralidhar S, Pumfery AM, Hassani M, Sadaie MR, Kishishita M, et al. (1998) Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J Virol 72: 4980-4988.
7. Sadler R, Wu L, Forghani B, Renne R, Zhong W, et al. (1999) A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J Virol 73: 5722-5730.
8. McAllister SC, Moses AV, (2007) Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology. Curr Top Microbiol Immunol 312: 211-244.
9. Ganem D, (2010) KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J Clin Invest 120: 939-949.
10. Dayan AD, Lewis PD, (1967) Origin of Kaposi's sarcoma from the reticulo-endothelial system. Nature 213: 889-890.
11. Aguilar B, Hong YK, (2010) The origin of Kaposi sarcoma tumor cells. In: Pantanowitz L, Stebbing J, Dezube BJ, editors. pp. 123-138 editors. Kaposi Sarcoma A Model of Oncogenesis: Research Signpost. pp.
12. Wang HW, Trotter MW, Lagos D, Bourboulia D, Henderson S, et al. (2004) Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36: 687-693.
13. Hong YK, Foreman K, Shin JW, Hirakawa S, Curry CL, et al. (2004) Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet 36: 683-685.
14. Carroll PA, Brazeau E, Lagunoff M, (2004) Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation. Virology 328: 7-18.
15. Sivakumar R, Sharma-Walia N, Raghu H, Veettil MV, Sadagopan S, et al. (2008) Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications. J Virol 82: 1759-1776.
16. Wigle JT, Oliver G, (1999) Prox1 function is required for the development of the murine lymphatic system. Cell 98: 769-778.
17. Wigle JT, Harvey N, Detmar M, Lagutina I, Grosveld G, et al. (2002) An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 21: 1505-1513.
18. Groger M, Loewe R, Holnthoner W, Embacher R, Pillinger M, et al. (2004) IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells. J Immunol 173: 7161-7169.
19. Oka M, Iwata C, Suzuki HI, Kiyono K, Morishita Y, et al. (2008) Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. Blood 111: 4571-4579.
20. Flister MJ, Wilber A, Hall KL, Iwata C, Miyazono K, et al. (2010) Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. Blood 115: 418-429.
21. Francois M, Caprini A, Hosking B, Orsenigo F, Wilhelm D, et al. (2008) Sox18 induces development of the lymphatic vasculature in mice. Nature 456: 643-647.
22. Kang J, Yoo J, Lee S, Tang W, Aguilar B, et al. (2010) An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells. Blood 116: 140-150.
23. Liang Y, Chang J, Lynch SJ, Lukac DM, Ganem D, (2002) The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev 16: 1977-1989.
24. Curry CL, Reed LL, Broude E, Golde TE, Miele L, et al. (2007) Notch inhibition in Kaposi's sarcoma tumor cells leads to mitotic catastrophe through nuclear factor-kappaB signaling. Mol Cancer Ther 6: 1983-1992.
25. Emuss V, Lagos D, Pizzey A, Gratrix F, Henderson SR, et al. (2009) KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia. PLoS Pathog 5: e1000616.
26. Sharma-Walia N, Paul AG, Bottero V, Sadagopan S, Veettil MV, et al. (2010) Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion. PLoS Pathog 6: e1000777.
27. Reddy EP, Korapati A, Chaturvedi P, Rane S, (2000) IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled. Oncogene 19: 2532-2547.
28. Yu H, Pardoll D, Jove R, (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9: 798-809.
29. Lan K, Verma SC, Murakami M, Bajaj B, Kaul R, et al. (2007) Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein. Proc Natl Acad Sci U S A 104: 16287-16292.
30. Curry CL, Reed LL, Golde TE, Miele L, Nickoloff BJ, et al. (2005) Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells. Oncogene 24: 6333-6344.
31. Iso T, Kedes L, Hamamori Y, (2003) HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 194: 237-255.
32. Lee S, Kang J, Yoo J, Ganesan SK, Cook SC, et al. (2009) Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate. Blood 113: 1856-1859.
33. Shin JW, Min M, Larrieu-Lahargue F, Canron X, Kunstfeld R, et al. (2006) Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis. Mol Biol Cell 17: 576-584.
34. Lee S, Choi I, Hong YK, (2010) Heterogeneity and plasticity of lymphatic endothelial cells. Semin Thromb Hemost 36: 352-361.
35. Aird W, (2007) Endothelial Biomedicine. WC A, editor. New York, NY: Cambridge University Press. 1856 p.
36. Gould F, Harrison SM, Hewitt EW, Whitehouse A, (2009) Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway. J Virol 83: 6727-6738.
37. Yada K, Do E, Sakakibara S, Ohsaki E, Ito E, et al. (2006) KSHV RTA induces a transcriptional repressor, HEY1 that represses rta promoter. Biochem Biophys Res Commun 345: 410-418.
38. Nicholas J, (2010) Human herpesvirus 8-encoded cytokines. Future Virol 5: 197-206.
39. Chandran B, (2010) Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells. J Virol 84: 2188-2199.
40. Morris VA, Punjabi AS, Lagunoff M, (2008) Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells. J Virol 82: 8771-8779.
41. Wei L, Laurence A, O'Shea JJ, (2008) New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiation. Semin Cell Dev Biol 19: 394-400.
42. McCormick C, Ganem D, (2005) The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 307: 739-741.
43. Ebner S, Hofer S, Nguyen VA, Furhapter C, Herold M, et al. (2002) A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern. J Immunol 168: 6199-6207.
44. Ogawa K, Hashida R, Miyagawa M, Kagaya S, Sugita Y, et al. (2003) Analysis of gene expression in peripheral blood eosinophils from patients with atopic dermatitis and in vitro cytokine-stimulated blood eosinophils. Clin Exp Immunol 131: 436-445.
45. Bates ME, Liu LY, Esnault S, Stout BA, Fonkem E, et al. (2004) Expression of interleukin-5- and granulocyte macrophage-colony-stimulating factor-responsive genes in blood and airway eosinophils. Am J Respir Cell Mol Biol 30: 736-743.
46. Gregory B, Kirchem A, Phipps S, Gevaert P, Pridgeon C, et al. (2003) Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alpha expression. J Immunol 170: 5359-5366.
47. Liu R, Li X, Tulpule A, Zhou Y, Scehnet JS, et al. (2010) KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood 115: 887-895.
48. Kang J, Ramu S, Lee S, Aguilar B, Ganesan SK, et al. (2009) Phosphate-buffered saline-based nucleofection of primary endothelial cells. Anal Biochem 386: 251-255.
49. Hong YK, Harvey N, Noh YH, Schacht V, Hirakawa S, et al. (2002) Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn 225: 351-357.
50. Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, et al. (2001) Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 20: 3427-3436.
51. Havrda MC, Johnson MJ, O'Neill CF, Liaw L, (2006) A novel mechanism of transcriptional repression of p27kip1 through Notch/HRT2 signaling in vascular smooth muscle cells. Thromb Haemost 96: 361-370.
52. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, et al. (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95: 2509-2514.
53. Woelfle J, Rotwein P, (2004) In vivo regulation of growth hormone-stimulated gene transcription by STAT5b. Am J Physiol Endocrinol Metab 286: E393-401.
54. Yoo J, Kang J, Lee HN, Aguilar B, Kafka D, et al. (2010) Kaposin-B enhances the PROX1 mRNA stability during lymphatic reprogramming of vascular endothelial cells by Kaposi's sarcoma herpes virus. PLoS Pathog 6: e1001046.
55. Nakagawa O, McFadden DG, Nakagawa M, Yanagisawa H, Hu T, et al. (2000) Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of Notch signaling. Proc Natl Acad Sci U S A 97: 13655-13660.
56. Maier MM, Gessler M, (2000) Comparative analysis of the human and mouse Hey1 promoter: Hey genes are new Notch target genes. Biochem Biophys Res Commun 275: 652-660.
57. Darling AE, Mau B, Perna NT, (2010) progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One 5: e11147.